Latest News about JNJ
Recent news which mentions JNJ
   Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit
   
  
  
  January 05, 2024
  From Benzinga
 
   Still Worried About a 2024 Recession? 7 Stocks to Watch.
   
  
  
  January 04, 2024
  From InvestorPlace
 
   Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
   
  
  
  January 04, 2024
  From Benzinga
 
   Revenge of the Boring Stocks! Dividends Are Sexy Again.
   
  
  
  January 03, 2024
  From InvestorPlace
 
   This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns
   
  
  
  January 03, 2024
  From Benzinga
 From Benzinga
 
   3 No-Brainer Stocks to Buy With $1,000 Right Now for the New Year
   
  
  
  January 03, 2024
  From Motley Fool
 From Benzinga
 
   Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024
   
  
  
  January 02, 2024
  From Benzinga
 From Benzinga
 
   2024’s Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns
   
  
  
  January 01, 2024
  From InvestorPlace
 
   Meet the 2024 Dogs of the Dow
   
  
  
  January 01, 2024
  From Motley Fool
 From Motley Fool
 
   Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires
   
  
  
  December 31, 2023
  From InvestorPlace
 
   2 Best Warren Buffett Stocks to Buy for the Long Haul
   
  
  
  December 30, 2023
  From Motley Fool
 
   Unpacking the Latest Options Trading Trends in Johnson & Johnson
   
  December 29, 2023
  Tickers 
   JNJ
  
  
  From Benzinga
 
   There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
   
  
  
  December 29, 2023
  From Motley Fool
 
   Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times
   
  
  
  December 29, 2023
  From InvestorPlace
 
   Contagious Opportunities: Norovirus Cases Are On The Rise, These Are The Stocks That May Be Impacted
   
  
  
  December 28, 2023
  From Benzinga
 
   Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024
   
  
  
  December 28, 2023
  From InvestorPlace
 
   Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
   
  
  
  December 28, 2023
  From Benzinga
 
   Why Is Blood Purification Focused CytoSorbents Trading Lower Today?
   
  
  
  December 28, 2023
  From Benzinga
 
   Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
   
  
  
  December 28, 2023
  From Benzinga
 From Motley Fool
 
   Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness
   
  
  
  December 27, 2023
  From InvestorPlace
 
   Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year?
   
  
  
  December 27, 2023
  From Motley Fool
 
   3 No-Brainer Stocks to Buy With $200 Right Now
   
  
  
  December 27, 2023
  From Motley Fool
 
   Nasdaq Leads Over NYSE in IPO Listings, Drawing Major Tech and Global Firms in 2023
   
  
  
  December 26, 2023
  From Benzinga
 
   7 Rock-Solid Dividend Stocks to Trust in Difficult Times
   
  
  
  December 25, 2023
  From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.